Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Rating) by 10.5% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 23,284 shares of the medical device company’s stock after purchasing an additional 2,220 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Tandem Diabetes Care were worth $2,708,000 at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of TNDM. Exane Derivatives bought a new stake in Tandem Diabetes Care in the 1st quarter valued at about $33,000. Byrne Asset Management LLC bought a new stake in shares of Tandem Diabetes Care during the 4th quarter worth approximately $34,000. CI Investments Inc. lifted its holdings in shares of Tandem Diabetes Care by 10,566.7% during the 1st quarter. CI Investments Inc. now owns 320 shares of the medical device company’s stock worth $37,000 after acquiring an additional 317 shares during the period. Sandy Cove Advisors LLC bought a new stake in shares of Tandem Diabetes Care during the 1st quarter worth approximately $46,000. Finally, KRS Capital Management LLC bought a new stake in shares of Tandem Diabetes Care during the 4th quarter worth approximately $60,000. Institutional investors own 95.28% of the company’s stock.
Tandem Diabetes Care Trading Up 4.3 %
Shares of NASDAQ TNDM opened at $45.65 on Thursday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 5.36 and a current ratio of 6.00. Tandem Diabetes Care, Inc. has a 52-week low of $42.90 and a 52-week high of $155.86. The firm has a 50 day moving average price of $55.71 and a two-hundred day moving average price of $78.95. The stock has a market cap of $2.93 billion, a P/E ratio of -207.50 and a beta of 0.95.
Analyst Upgrades and Downgrades
Tandem Diabetes Care Profile
Tandem Diabetes Care, Inc, a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set.
- Get a free copy of the StockNews.com research report on Tandem Diabetes Care (TNDM)
- 3 High Margin Chipmakers Bound to Recover
- 3 Solar Stocks That Will Benefit From the Biden Tariff Holiday
- REV Group Has A Deep Moat In The World Of EVs
- Is G-III Apparel Group, Ltd. A Value Trap?
- Bank Of America Sees Upside In These 2 European Alcohol Stocks
Receive News & Ratings for Tandem Diabetes Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tandem Diabetes Care and related companies with MarketBeat.com's FREE daily email newsletter.